Mycobacterium Tuberculosis Testing Controls

Tuberculosis remains a serious global health threat, making accurate, timely diagnosis essential for effective treatment and limiting transmission. INTROL TB Panel M110 is a comprehensive external quality control for molecular detection of Mycobacterium tuberculosis (MTB) and MDR-TB mutations that monitors extraction, amplification, and detection steps to help laboratories deliver reliable results clinicians and patients can trust.

Delayed or inaccurate TB diagnosis can impact treatment success and disease spread, dependable quality controls are essential. INTROL TB Panel M114 supports performance monitoring of GeneXpert^®-based MTB testing, including detection of drug-resistant variants, helping laboratories confirm assay accuracy so providers can make informed patient care decisions.

Early, precise identification of TB and resistant strains is critical to guiding therapy and improving patient outcomes. Designed for use with GeneXpert^® MTB assays, INTROL TB Panel M114plus verifies detection of MTB and key drug-resistance markers, helping labs ensure consistent assay performance and confidence in every reported result.

A dedicated negative control for GeneXpert^® MTB assays, INTROL TBNEG-30 confirms the absence of M. tuberculosis DNA and helps detect contamination. Reliable negative results are just as important as positive ones, providing reassurance for patients and clinicians when ruling out active TB infection.

Designed for the GeneXpert^® MTB/XDR assay INTROL TB-XDR Panel M345 include wild-type, mutant, and negative controls to monitor the detection of extensively drug-resistant TB (XDR-TB). Accurate detection of drug-resistant strains is critical for effective treatment and patient care, helping clinicians identify resistance quickly and guide therapy confidently.